Alumasc (ALU): Corp Interim results – continued subdued market conditions | ANGLE (AGL): Corp Interims – FDA study 92% recruited | Aukett Swanke (AUK): Corp Final results | Cambridge Cognition (COG): Corp Pharma partnership/new product delivers £0.2m upfront | discoverIE (DSCV): Corp 10% organic growth up from 7% in H1 | eServGlobal (ESG): Corp PayMobile extends service in the Middle East | Filtronic (FTC): Corp Initiation: Critical Coms provide
31 Jan 2019
Morning Note – 31 January 2019
discoverIE Group PLC (DSCV:LON), 740 | Alumasc Group plc (ALU:LON), 172 | Frenkel Topping Group plc (FEN:LON), 51.5 | Molecular Energies PLC (MEN:LON), 6.0 | Filtronic plc (FTC:LON), 37.0
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Morning Note – 31 January 2019
discoverIE Group PLC (DSCV:LON), 740 | Alumasc Group plc (ALU:LON), 172 | Frenkel Topping Group plc (FEN:LON), 51.5 | Molecular Energies PLC (MEN:LON), 6.0 | Filtronic plc (FTC:LON), 37.0
- Published:
31 Jan 2019 -
Author:
Guy Hewett | Mark Paddon | Mark Brewer | Jonathan Wright | Cavendish Research -
Pages:
17
Alumasc (ALU): Corp Interim results – continued subdued market conditions | ANGLE (AGL): Corp Interims – FDA study 92% recruited | Aukett Swanke (AUK): Corp Final results | Cambridge Cognition (COG): Corp Pharma partnership/new product delivers £0.2m upfront | discoverIE (DSCV): Corp 10% organic growth up from 7% in H1 | eServGlobal (ESG): Corp PayMobile extends service in the Middle East | Filtronic (FTC): Corp Initiation: Critical Coms provide